Definitive Contract W911QY20C0100
Award Date
8/11/20
Potential Completion Date
8/10/23
Potential Value
$8.2B
Funding Federal Agency
Joint PEO Chemical and Biological Defense
Contracting Federal Agency
ACC Aberdeen Proving Ground
Awardee
Modernatx, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02139, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This definitive contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Moderna US, Inc. for COVID-19 vaccinations in support of the 2022 Fall Vaccine Campaign. The $7.8 billion firm fixed price contract is a transfer from the original awarding agency, the Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense, and represents continuation of vaccine production...
<p>The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense (DOD - Army - USASC) awarded a Definitive Contract valued at $7,837,399,999.00 to Moderna US, Inc. Moderna US Inc. Division for COVID-19 MRNA Vaccines. The place of performance will be in Cambridge, MA 02139, USA and the period of performance is from July 28, 2022 through March 31, 2023. The pricing structure is Firm Fixed Price.</p>
This federal contract award, valued at $1,908.33, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under Emergency Use Authorization (EUA), with an ultimate completion date of November 12, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, valued at $5,115.96, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,605.08 firm fixed-price delivery order is for the supply of Moderna COVID-19 vaccines for individuals aged 6 months to 11 years under the Emergency Use Authorization (EUA). The award has an ultimate completion date of December 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $15,189.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 0.25 mL doses of the Moderna COVID-19 vaccine for individuals aged 6 months to 11 years under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of November 27, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
This federal contract award, valued at $16,888.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.25mL doses of the Moderna COVID-19 vaccine for individuals aged 6 months to 11 years, under the Emergency Use Authorization (EUA). The award has an ultimate completion date of October 20, 2023. This contract is a delivery order with a firm fixed-price...
This federal contract award, valued at $2,215.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor to the U.S. government. The contract is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to...
This federal contract award, valued at $4,556.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). This is a firm-fixed-price contract with a completion date of November 13, 2023. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the federal government...
This federal contract award is for the delivery of 0.25 mL doses of the Moderna COVID-19 vaccine for the 6-month to 11-year age group under the Emergency Use Authorization (EUA). The $1,290.00 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 30, 2024 and does not have a set-aside designation, indicating...